Home
About Us
Company Overview
Executive Leadership Team
Board of Directors
Careers
Physicians &
Nurses
Pure-Vu EVS System
User Testimonials
Clinical Evidence
Investigator-Initiated Study
Helpful Hints
Inpatient Upper GI Endoscopy (EGD)
Inpatient Colonoscopy
Outpatient Colonoscopy
Frequently Asked Questions
Facility
Administrators
Overview
User Testimonials
Clinical Evidence
News &
Media
Customer Notices
Customer Notices
Content Library
Investors
Overview
News & Events
Company Information
Financial Results
Stock Data
SEC Filings
Governance
Help
Search
Search
SEC Filings
Investor Tools
Email Alerts
Contacts
RSS News Feed
SEC Filings
Quick Links
Overview
All
SEC Filings
Annual &
Quarterly Reports
Section
16 Filings
Latest Quarterly or Annual Filing
10-Q
May 14, 2024
Quarterly report pursuant to Section 13 or 15(d)
1 2024
Quarter Results
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
View PDF
View HTML
View Quarterly & Annual Reports
Latest Current Report
8-K
June 20, 2024
Current report filing
View PDF
View HTML
Latest Proxy Statement
DEF 14A
June 26, 2024
Definitive proxy statements
View PDF
View HTML
View Section 16 Filings
View All SEC Filings
SIGN-UP FOR EMAIL ALERTS
We're sorry
, but this form has spam protection that requires JavaScript to be enabled to work correctly. If you'd like to contact us via this form, please
enable scripts in your browser
and reload the page.
First Name
Last Name
Email Address
Phone
Country
Contact Type:
Individual Investor
Analyst
Broker/Investment Advisor
Portfolio Manager
Banker/Financing Source
Press/Media
Consultant
Employee
Customer/Client
Student
Other
All Press Releases
All SEC Filings
10-K & 10-Q Reports
Current Reports
Insider Transactions
Proxy Information
Comments
This site is protected by hCaptcha and its
Privacy Policy
and
Terms of Service
apply.
Submit
